Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (NIH HEAL Initiative)

Funded by the NIH HEAL Initiative®

This study will examine if rapid transition to extended release naltrexone (XR-NTX) following detoxification yields a higher proportion of patients successfully receiving the first injection of XR-NTX compared to standard detoxification and naltrexone initiation and will assess facilitators and barriers to implementing rapid XR-NTX initiation.

NCT04762537

Adam Bisaga, M.D.

Research Psychiatrist

New York State Psychiatric Institute

1051 Riverside Drive, Unit 120 , New York, NY, 10032, US

adam.bisaga@nyspi.columbia.edu

Edward V. Nunes, Jr., M.D.

Professor of Clinical Psychiatry

Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute

1051 Riverside Drive, Unit 51, Room 3717, New York, NY, 10032, US

edward.nunes@nyspi.columbia.edu

CTN-0097 completed